Collegium Pharmaceutical, Inc (COLL) income statement
COLLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3048% below fair value
$25.55+0.12 (+0.47%)
Close on Nov 17, 2026Market cap $831.80MP/E 20.6Yield –
Collegium Pharmaceutical, Inc income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 60.0%
- Operating margin
- 19.5%
- Net margin
- 5.9%
- Return on equity, FY2025
- 23.7%
Financial strength
- Current ratio
- 1.03
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 21.9%
Valuation
- P/E ratio
- 20.6
- Price to sales
- 1.03
- Price to book
- 2.67
- Dividend yield
- –
See a number that looks wrong?